Interleukin 17 Inhibitors
2021
Abstract IL-17 is an important cytokine responsible in the pathogenesis of both plaque psoriasis and psoriatic arthritis. Secukinumab, ixekizumab, and brodalumab are all drugs with unique pharmacologic and immunologic properties that are used to effectively and safely treat psoriatic disease.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI